Etoposide Capsule and Insulin Degludec (U-200) Prefilled Pens
Determining the interaction of Etoposide Capsule and Insulin Degludec (U-200) Prefilled Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: etoposide
Brand name: VePesid, Etopophos, Toposar
Synonyms: Etoposide
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Etoposide Capsule-Insulin degludec and liraglutide
- Etoposide Capsule-Insulin degludec and liraglutide Subcutaneous
- Etoposide Capsule-Insulin degludec Subcutaneous
- Etoposide Capsule-Insulin detemir
- Etoposide Capsule-Insulin Detemir (Cartridges and Prefilled Syringes)
- Etoposide Capsule-Insulin Detemir (Vials)
- Insulin Degludec (U-200) Prefilled Pens-Etoposide Capsules
- Insulin Degludec (U-200) Prefilled Pens-Etoposide injection
- Insulin Degludec (U-200) Prefilled Pens-Etoposide Oral, Intravenous
- Insulin Degludec (U-200) Prefilled Pens-Etoposide phosphate
- Insulin Degludec (U-200) Prefilled Pens-Etrafon
- Insulin Degludec (U-200) Prefilled Pens-Etrafon Forte